Suppressive antibiotic therapy with oral doxycycline for Staphylococcus aureus prosthetic joint infection: a retrospective study of 39 patients

Parvizi, 2012, Management of periprosthetic joint infection: the current knowledge: AAOS exhibit selection, J Bone Joint Surg Am, 94, e104, 10.2106/JBJS.K.01417 Osmon, 2013, Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America, Clin Infect Dis, 56, e1, 10.1093/cid/cis803 Saivin, 1988, Clinical pharmacokinetics of doxycycline and minocycline, Clin Pharmacokinet, 15, 355, 10.2165/00003088-198815060-00001 Landersdorfer, 2009, Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations, Clin Pharmacokinet, 48, 89, 10.2165/00003088-200948020-00002 Agwuh, 2006, Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines, J Antimicrob Chemother, 58, 256, 10.1093/jac/dkl224 Thompson, 2011, Pharmacological agents for soft tissue and bone infected with MRSA: which agent and for how long?, Injury, 42, S7, 10.1016/S0020-1383(11)70126-7 Bocker, 1986, Serum level, half-life and apparent volume of distribution of doxycycline in geriatric patients, Eur J Clin Pharmacol, 30, 105, 10.1007/BF00614205 Forcade, 2011, Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) Study, J Am Board Fam Med, 24, 543, 10.3122/jabfm.2011.05.110073 Zimmerli, 2004, Prosthetic-joint infections, N Engl J Med, 351, 1645, 10.1056/NEJMra040181 Byren, 2009, One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome, J Antimicrob Chemother, 63, 1264, 10.1093/jac/dkp107 Smith, 2011, Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects, Arthritis Res Ther, 13, R168, 10.1186/ar3491 Smith, 2005, Safety of doxycycline and minocycline: a systematic review, Clin Ther, 27, 1329, 10.1016/j.clinthera.2005.09.005 Segreti, 1998, Prolonged suppressive antibiotic therapy for infected orthopedic prostheses, Clin Infect Dis, 27, 711, 10.1086/514951 Rao, 2003, Long-term suppression of infection in total joint arthroplasty, Clin Orthop Relat Res, 414, 55, 10.1097/01.blo.0000087321.60612.cf Goulet, 1988, Prolonged suppression of infection in total hip arthroplasty, J Arthroplasty, 3, 109, 10.1016/S0883-5403(88)80075-5 Tsukayama, 1991, Suppressive antibiotic therapy in chronic prosthetic joint infections, Orthopedics, 14, 841, 10.3928/0147-7447-19910801-07 Prendki, 2014, Outcome of patients over 80 years of age on prolonged suppressive antibiotic therapy for at least 6 months for prosthetic joint infection, Int J Infect Dis, 29, 184, 10.1016/j.ijid.2014.09.012 Siqueira, 2015, Chronic suppression of periprosthetic joint infections with oral antibiotics increases infection-free survivorship, J Bone Joint Surg Am, 97, 1220, 10.2106/JBJS.N.00999 Koeppe, 2008, Suppressive antibiotic therapy for retained infected prosthetic joints: case series and review of the literature, Infect Dis Clin Pract (Baltim Md), 16, 224, 10.1097/IPC.0b013e31816d2118 Aboltins, 2007, Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid, Clin Microbiol Infect, 13, 586, 10.1111/j.1469-0691.2007.01691.x Lora-Tamayo, 2013, A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention, Clin Infect Dis, 56, 182, 10.1093/cid/cis746 Cobo, 2011, Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy, Clin Microbiol Infect, 17, 1632, 10.1111/j.1469-0691.2010.03333.x Senneville, 2011, Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus, Clin Infect Dis, 53, 334, 10.1093/cid/cir402 Betsch, 2008, Treatment of joint prosthesis infection in accordance with current recommendations improves outcome, Clin Infect Dis, 46, 1221, 10.1086/529436 Fenske, 1980, Minocycline-induced pigmentation at sites of cutaneous inflammation, JAMA, 244, 1103, 10.1001/jama.1980.03310100021021 Lawrenson, 2000, Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data, Drug Saf, 23, 333, 10.2165/00002018-200023040-00006 Dağ, 2014, Gülşen MT. Drug-induced esophageal ulcers: case series and the review of the literature, Turk J Gastroenterol, 25, 180, 10.5152/tjg.2014.5415 Hung, 2015, Doxycycline and tigecycline: two friendly drugs with a low association with Clostridium difficile infection, Antibiotics (Basel), 4, 216, 10.3390/antibiotics4020216 Doernberg, 2012, Does doxycycline protect against development of Clostridium difficile infection?, Clin Infect Dis, 55, 615, 10.1093/cid/cis457 Turner, 2014, Role of doxycycline in Clostridium difficile infection acquisition, Ann Pharmacother, 48, 772, 10.1177/1060028014528792